Medifast Inc

Medifast Inc

MED

Get informed when a big investor buys or sells

+ Follow
Market Cap$137.72M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medifast IncMedifast Inc-5--13%0.40.2
$41.67

Current Fair Value

245.5% upside

Undervalued by 245.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$137.72 Million
Enterprise Value$98.68 Million
Dividend Yield$- (-)
Earnings per Share$-1.7
Beta0.7
Outstanding Shares11,135,000

Return

Return on Equity-13.04%ROE
Return on Assets-9.83%
Return on Invested Capital-7.30%

Valuation & Multiples

P/E Ratio-4.98P/E Ratio
PEG2.21PEG
Price to Sales0.43Price to Sales
Price to Book Ratio0.71Price to Book Ratio
Enterprise Value to Revenue0.31
Enterprise Value to EBIT-6.18
Enterprise Value to Net Income-4
Total Debt to Enterprise0.33
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 3, 2026
EPS Estimate
$-0.65
Average shareholder expectation
Revenue Estimate
$72.70 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$-0.35
Average shareholder expectation
Revenue Estimate
$71.30 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 11.47%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.01%▼ 77.75%
Total Invested$15,494▼ 99.98%
Investors Holding4▼ 116.00%

ESG Score

No data

About Medifast Inc

550 employees
CEO: Daniel Chard

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...